Myocarditis diagnosis: the importance of the 1-year outcomes of the EURO/Observational Research Programme: Cardiomyopathy/Myocarditis Long-Term Registry!

#endomyocardial #biopsy #cardiac #MRI #EHJ #cardiotwitter European Society of Cardiology Journals European Society of Cardiology

academic.oup.com/eurheartj/adva…

#worldhypertensionday #HypertensionPrevention #bloodpressure #cardiotwitter #knowyournumbers

🔥Out now in #JCF ! This brief report shows that in the ongoing FINEARTS-HF trial, incorporating UACR reclassified kidney risk in 1/3 trial pts and US adults with HF, emphasizing the importance of albuminuria as part of comprehensive risk assessment.

🔗bit.ly/3UTfys8

🚨1st SHORE pub‼️ > 2k🫀transplants, dual non-invasive rejection surveillance with GEP & dd-cfDNA:
1. ⬆️yield for ACR over either test alone
2. ⬇️number of biopsies
3. Great survival and🫀LVEF
Kiran Khush JHLT The ISHLT American Society of Transplantation (AST) HFSA Nir Uriel, MD MSc
jhltonline.org/article/S1053-…

On-treatment analysis of #TRANSFORM_HF led by Mark Kittipibul MD now in European Society of Cardiology Journals #EJHF

Among patients adherent to randomized diuretic, no significant difference in outcomes w #torsemide vs #furosemide . Further supports message of original trial results.

onlinelibrary.wiley.com/doi/full/10.10…

⁉️What would it like when #Heart_Failure care is 'outsourced' to help with med titration, follow up and prevention of HF hospitalizations
➡️ Now we have such data

sciencedirect.com/science/articl…
In follow up: There were decreases in systolic blood pressure -7 and↗️in HF meds Journal of Cardiac Failure

Honored, humbled and extremely excited to be part of this fantastic new #HFA board 2024-2026
➡️ Together with Marco Metra we will be inclusive and reunite East, West, North and South !
➡️ Leave no one behind, really no one !
➡️ Grow Together !

#EuroPCR #JACC SimPub: In the bRIGHT study, tricuspid #TEER w/ #TriClip is safe & effective through 1-yr for sig. TR in a real-world population. 1-yr mortality is assoc w/ residual severe or greater TR, elevated BL serum creatinine, & smaller RV TAPSE. bit.ly/4bEVbEE

1. The magic of Paris by night at #EuroPCR2024 Hany Ragy MIЯVΛƬ #IC chief Julia Grapsa Erik Rafflenbeul Khaled AlShaibi Wail AlkashkariFSCAI,FPICSوائل القشقرى🇸🇦🇨🇦🇺🇲 Dr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦 Ritu Thamman MD Dr. Purvi Parwani Tuğba Kemaloğlu Öz, A/Prof Shelley Zieroth Ekaterini Lambrinou💙 Vass Vassiliou Dr. Lucio T Padilla🇦🇷

#EuroPCR #JACC LBCT SimPub: Insights from #REVIVED -BCIS2 trial - Completeness of #revascularization , whether anatomical or viability-guided, does not influence outcomes in patients with ischemic #cardiomyopathy . bit.ly/44JRcV0

Saad Ezad Margaret McEntegart Cardiac Research

So much 🗣️ about the overlap Btwn #FunctionNotFailure & #CriticalCareCardiology - After some research, countless conversations & info from ACGME comes this thoughtful Early Career Trainee Spotlight 🔦 Syed Zain Ali & Anthony Carnicelli, MD FACC Journal of Cardiac Failure 👇🏽👇🏽👇🏽

Happy Birthday to the amazing Dr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦 - someone who brings a lot of love and light into this world. 😊✨🎂

Wow. Even in an open label trial, PCI in the “perfect” patient (amenable anatomy + viability) did not result in QOL improvements at one year over simple tablets.

REVIVED continues to shock the cardiology community

Link jacc.org/doi/10.1016/j.…

Dr. Laura Cohen presenting the #TEAMHF echo data after rapid #GDMTworks clinic titration

Average 6% LVEF rise
>60% with 🔼LVEF from below to above 35%
50% 🔽in 3-4+ MR

These results emphasize the value of GDMT programs!

Mass General Heart HFAPresident

Physician perceptions, attitudes, & strategies towards implementing guideline-directed medical therapy in #HF w/ reduced ejection fraction

A survey of the #HF A_ESC Association of European Society of Cardiology & the ESC Council for Cardiology Practice bit.ly/4bAlADv

#HeartFailure2024

The #SEQUOIA #HCM trial results are here - Placebo-controlled trial of #aficamten in #obstructive #HCM

3 presentations in 3 threads - follow along

This is the first presentation by Martin Maron, MD sharing the primary results
Follow along #CardioTwitter #HeartFailure2024

What is a cost-effective GDMT strategy for HFmrEF/HFpEF?

We built a model w/ clinical trial data (TOPCAT, PARAGON-HF, EMPEROR/DELIVER) and simulated outcomes w/ regimens of MRA/SGLT2i/ARNi.

Best 💊 combo?
MRA + SGLT2i

ARNi ⬇️ value at current 💵

Treat HF with urgency!

The Pragmatic Urinary Sodium-based algoritHm in Acute Heart Failure

🔴 #PUSH -AHF trial randomized patients to natriuresis-guided diuretic therapy or standard of care #HeartFailure2024

👥309 patients
📌median baseline eGFR was 53

👉Natriuresis-guided diuretic treatment

#HeartFailure2024 #JACC SimPub: In #ATTR -CA, the baseline 6MWT distance can refine risk stratification beyond traditional prognosticators. Worsening of 6MWT at 1 year was common and independently associated with an increased risk of mortality. bit.ly/44zzYtt #Amyloidosis

🔥LBCT at #HeartFailure2024 and simultaneous publication in #EHJ :
✅ Semaglutide and Diuretic Use in Obesity-Related #HFpEF : A Pooled Analysis of the STEP-HFpEF and STEP-HFpEF-DM trials

⁦Mark Petrie⁩ ⁦Shelley Zieroth⁩ ⁦⁦EHJ Editor-in-Chief⁩ academic.oup.com/eurheartj/adva…